보톡스 시장(2026-2030년)

The global botox market is forecasted to grow by USD 6215.9 mn during 2025-2030, accelerating at a CAGR of 10.7% during the forecast period. The report on the global botox market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating global demand for minimally invasive aesthetic procedures, rapid expansion of approved therapeutic and clinical applications, demographic transitions and rise of preventative geriatric care.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global botox market is segmented as below:

By Application

• Aesthetic
• Medical

By End-User

• Hospitals
• Dermatology clinics
• Others

By Gender

• Female
• Male

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Russia
  • Italy
  • Spain
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the proliferation of ready-to-use liquid formulations and next-generation neuromodulators as one of the prime reasons driving the global botox market growth during the next few years. Also, mainstream integration of full-face contouring and micro-dosing techniques and demographic diversification driven by preventative pre-aging treatments and male consumer influx will lead to sizable demand in the market.

The report on the global botox market covers the following areas:

• Global botox market sizing
• Global botox market forecast
• Global botox market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global botox market vendors that include AbbVie Inc., Bausch Health Co Inc., China National Biotec Group, Croma-Pharma GmbH, Daewoong Pharmaceutical Co. Ltd., Evolus Inc., Galderma Group AG, Hugel Inc., Huons Global Co. Ltd., Ipsen Pharma, Medytox Inc., Merz Pharma GmbH KGaA, Object Pharma Inc., PharmaResearch Co. Ltd., Revance Therapeutics Inc., Supernus Pharmaceuticals Inc.. Also, the global botox market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Gender
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Botox Market 2020 - 2024
  • Historic Market Size - Data Table on Global Botox Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Gender segment analysis 2020 - 2024
  • Historic Market Size - Gender Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global botox market
• 6.2 Impact of geopolitical conflicts on global botox market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Aesthetic - Market size and forecast 2025-2030
• 8.4 Medical - Market size and forecast 2025-2030
• 8.5 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2025-2030
• 9.4 Dermatology clinics - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Gender

• 10.1 Market segments
• 10.2 Comparison by Gender
• 10.3 Female - Market size and forecast 2025-2030
• 10.4 Male - Market size and forecast 2025-2030
• 10.5 Market opportunity by Gender
  • Market opportunity by Gender ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 France - Market size and forecast 2025-2030
  • 12.4.2 Germany - Market size and forecast 2025-2030
  • 12.4.3 UK - Market size and forecast 2025-2030
  • 12.4.4 Russia - Market size and forecast 2025-2030
  • 12.4.5 Italy - Market size and forecast 2025-2030
  • 12.4.6 Spain - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Singapore - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Australia - Market size and forecast 2025-2030
  • 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 South Africa - Market size and forecast 2025-2030
  • 12.6.6 Chile - Market size and forecast 2025-2030
  • 12.6.7 Israel - Market size and forecast 2025-2030
  • 12.6.8 Turkey - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Escalating global demand for minimally invasive aesthetic procedures
  • Rapid expansion of approved therapeutic and clinical applications
  • Demographic transitions and rise of preventative geriatric care
• 13.2 Market challenges
  • Proliferation of counterfeit formulations and unlicensed distribution networks
  • Escalating regulatory compliance burdens and intramuscular distribution safeguards
  • Intense pricing pressures and proliferation of low-cost biosimilars
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Proliferation of ready-to-use liquid formulations and next-generation neuromodulators
  • Mainstream integration of full-face contouring and micro-dosing techniques
  • Demographic diversification driven by preventative pre-aging treatments and male consumer influx

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Segment focus
  • SWOT
• 15.5 Bausch Health Co Inc.
  • Bausch Health Co Inc. - Overview
  • Bausch Health Co Inc. - Business segments
  • Bausch Health Co Inc. - Key offerings
  • Bausch Health Co Inc. - Segment focus
  • SWOT
• 15.6 China National Biotec Group
  • China National Biotec Group - Overview
  • China National Biotec Group - Product / Service
  • China National Biotec Group - Key offerings
  • SWOT
• 15.7 Daewoong Pharmaceutical Co. Ltd.
  • Daewoong Pharmaceutical Co. Ltd. - Overview
  • Daewoong Pharmaceutical Co. Ltd. - Product / Service
  • Daewoong Pharmaceutical Co. Ltd. - Key offerings
  • SWOT
• 15.8 Evolus Inc.
  • Evolus Inc. - Overview
  • Evolus Inc. - Product / Service
  • Evolus Inc. - Key offerings
  • SWOT
• 15.9 Galderma Group AG
  • Galderma Group AG - Overview
  • Galderma Group AG - Business segments
  • Galderma Group AG - Key offerings
  • Galderma Group AG - Segment focus
  • SWOT
• 15.10 Hugel Inc.
  • Hugel Inc. - Overview
  • Hugel Inc. - Product / Service
  • Hugel Inc. - Key offerings
  • SWOT
• 15.11 Huons Global Co. Ltd.
  • Huons Global Co. Ltd. - Overview
  • Huons Global Co. Ltd. - Product / Service
  • Huons Global Co. Ltd. - Key offerings
  • SWOT
• 15.12 Ipsen Pharma
  • Ipsen Pharma - Overview
  • Ipsen Pharma - Business segments
  • Ipsen Pharma - Key offerings
  • Ipsen Pharma - Segment focus
  • SWOT
• 15.13 Medytox Inc.
  • Medytox Inc. - Overview
  • Medytox Inc. - Product / Service
  • Medytox Inc. - Key offerings
  • SWOT
• 15.14 Merz Pharma GmbH KGaA
  • Merz Pharma GmbH KGaA - Overview
  • Merz Pharma GmbH KGaA - Product / Service
  • Merz Pharma GmbH KGaA - Key offerings
  • SWOT
• 15.15 Object Pharma Inc.
  • Object Pharma Inc. - Overview
  • Object Pharma Inc. - Product / Service
  • Object Pharma Inc. - Key offerings
  • SWOT
• 15.16 PharmaResearch Co. Ltd.
  • PharmaResearch Co. Ltd. - Overview
  • PharmaResearch Co. Ltd. - Product / Service
  • PharmaResearch Co. Ltd. - Key offerings
  • SWOT
• 15.17 Revance Therapeutics Inc.
  • Revance Therapeutics Inc. - Overview
  • Revance Therapeutics Inc. - Product / Service
  • Revance Therapeutics Inc. - Key offerings
  • SWOT
• 15.18 Supernus Pharmaceuticals Inc.
  • Supernus Pharmaceuticals Inc. - Overview
  • Supernus Pharmaceuticals Inc. - Product / Service
  • Supernus Pharmaceuticals Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations